Posts

Takeda v Roche: "Is it plausible? Is it true?"

Roche shields itself from a UK Arrow: Pfizer v Roche

Fordham 27 (Report 9): Biologics and Biosimilars

Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars

Biosimilars and generics as "rip-offs": when the facts may not matter

Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans

Will the Arrow hit the Humira target? Find out tomorrow!

AIPPI Congress Report 3: Biosimilars – similar but different?